Nucleic acid amplification technologies are for analysis of DNA. These methods are popular in the fields of recombinant DNA and molecular biology. Due to the growth in the instances of infectious diseases and other chronic diseases like cancer, researchers require better throughput in gene amplification. Rising research activities and governmental support and funding for the additional research and development activities are driving the global nucleic acid amplification technologies market. Growth in the end-user segments and advancing technologies are also expected to create a crucial role in the overall growth of the market.
Segmentation in INAAT Market
The global isothermal nucleic acid amplification technologies market is segmented on the basis of the types of products, which include reagents and instruments. The types of applications of these technologies are concentrated into infectious diseases, research and blood screening technologies. Hospitals, reference laboratories and such other institutes are the major end-users for the INAAT industry. On the basis of the geographic regions, the global market is segmented into North America, Europe, Asia Pacific and the rest of the world. Analysis of all these segments provides details of the trends, drivers, restraints and opportunities for the existing as well as new businesses in the market.
Drivers, Trends and Restraints
Growth in the number of infectious diseases, cancers and aging population are driving the demand for isothermal amplification technologies. Advancements of novel technologies like Nucleic Acid Sequence Based Amplification (NASBA), Helicase Dependent Amplification (HDA) and Loop-Mediated Isothermal Amplification (LAMP), etc. are driving the growth in demand for this industry. Advancing technologies in molecular biology and recombinant DNA are also creating rise in demand for the industry. Inadequate infrastructure and dominance of the PCR technology are expected to be the critical restraints for the market. Despite the restraints, the global market is gaining strength from growing research activities.
According to the analysis of the trends, drivers and segments of the markets, researchers are hoping for steady growth of the industry during the next few years to come. By 2018, the isothermal nucleic acid amplification technologies market is expected to grow at a CAGR of over 13%. At the projected growth rate, the market is expected to become worth more than $1,651 million by 2018. During the forecasting period, research of infectious diseases like hepatitis A and B and AIDS are expected to drive the demand. North America is expected to dominate the global market on the basis of demand and applications with about 44% of the total market share. Asian market on the other hand is set to grow at an impressive CAGR.